Logo image of CLDT

CHATHAM LODGING TRUST (CLDT) Stock Fundamental Analysis

NYSE:CLDT - New York Stock Exchange, Inc. - US16208T1025 - REIT - Currency: USD

6.82  -0.01 (-0.15%)

After market: 6.82 0 (0%)

Fundamental Rating

3

CLDT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 130 industry peers in the Diversified REITs industry. CLDT may be in some trouble as it scores bad on both profitability and health. CLDT has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CLDT had positive earnings in the past year.
In the past year CLDT had a positive cash flow from operations.
CLDT had negative earnings in 4 of the past 5 years.
Of the past 5 years CLDT 4 years had a positive operating cash flow.
CLDT Yearly Net Income VS EBIT VS OCF VS FCFCLDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

CLDT has a Return On Assets (0.23%) which is comparable to the rest of the industry.
CLDT has a Return On Equity (0.38%) which is in line with its industry peers.
The Return On Invested Capital of CLDT (2.17%) is worse than 62.31% of its industry peers.
CLDT had an Average Return On Invested Capital over the past 3 years of 2.14%. This is in line with the industry average of 3.15%.
The 3 year average ROIC (2.14%) for CLDT is below the current ROIC(2.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.23%
ROE 0.38%
ROIC 2.17%
ROA(3y)-0.19%
ROA(5y)-1.54%
ROE(3y)-0.33%
ROE(5y)-3%
ROIC(3y)2.14%
ROIC(5y)N/A
CLDT Yearly ROA, ROE, ROICCLDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5 -10

1.3 Margins

The Profit Margin of CLDT (0.89%) is comparable to the rest of the industry.
Looking at the Operating Margin, with a value of 10.12%, CLDT is doing worse than 78.46% of the companies in the same industry.
In the last couple of years the Operating Margin of CLDT has declined.
With a decent Gross Margin value of 75.86%, CLDT is doing good in the industry, outperforming 74.62% of the companies in the same industry.
In the last couple of years the Gross Margin of CLDT has remained more or less at the same level.
Industry RankSector Rank
OM 10.12%
PM (TTM) 0.89%
GM 75.86%
OM growth 3YN/A
OM growth 5Y-10.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.31%
CLDT Yearly Profit, Operating, Gross MarginsCLDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLDT is destroying value.
The number of shares outstanding for CLDT remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CLDT has more shares outstanding
The debt/assets ratio for CLDT has been reduced compared to a year ago.
CLDT Yearly Shares OutstandingCLDT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CLDT Yearly Total Debt VS Total AssetsCLDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

CLDT has an Altman-Z score of 0.40. This is a bad value and indicates that CLDT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CLDT (0.40) is comparable to the rest of the industry.
CLDT has a debt to FCF ratio of 10895.60. This is a negative value and a sign of low solvency as CLDT would need 10895.60 years to pay back of all of its debts.
With a Debt to FCF ratio value of 10895.60, CLDT perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
CLDT has a Debt/Equity ratio of 0.51. This is a neutral value indicating CLDT is somewhat dependend on debt financing.
CLDT has a Debt to Equity ratio of 0.51. This is amongst the best in the industry. CLDT outperforms 89.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 10895.6
Altman-Z 0.4
ROIC/WACC0.28
WACC7.62%
CLDT Yearly LT Debt VS Equity VS FCFCLDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.39 indicates that CLDT may have some problems paying its short term obligations.
CLDT has a worse Current ratio (0.39) than 81.54% of its industry peers.
CLDT has a Quick Ratio of 0.39. This is a bad value and indicates that CLDT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.39, CLDT is doing worse than 80.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
CLDT Yearly Current Assets VS Current LiabilitesCLDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 685.71% over the past year.
Measured over the past years, CLDT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -53.50% on average per year.
Looking at the last year, CLDT shows a small growth in Revenue. The Revenue has grown by 1.96% in the last year.
Measured over the past years, CLDT shows a decrease in Revenue. The Revenue has been decreasing by -0.68% on average per year.
EPS 1Y (TTM)685.71%
EPS 3YN/A
EPS 5Y-53.5%
EPS Q2Q%260%
Revenue 1Y (TTM)1.96%
Revenue growth 3Y15.86%
Revenue growth 5Y-0.68%
Sales Q2Q%-7.16%

3.2 Future

The Earnings Per Share is expected to grow by 125.83% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -2.49% on average over the next years.
EPS Next Y-406%
EPS Next 2Y125.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.98%
Revenue Next 2Y-2.49%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLDT Yearly Revenue VS EstimatesCLDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CLDT Yearly EPS VS EstimatesCLDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2 -2

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.63 indicates a correct valuation of CLDT.
CLDT's Price/Earnings ratio is rather cheap when compared to the industry. CLDT is cheaper than 88.46% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.48. CLDT is valued slightly cheaper when compared to this.
CLDT is valuated quite expensively with a Price/Forward Earnings ratio of 133.73.
CLDT's Price/Forward Earnings is on the same level as the industry average.
CLDT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 34.04.
Industry RankSector Rank
PE 16.63
Fwd PE 133.73
CLDT Price Earnings VS Forward Price EarningsCLDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

97.69% of the companies in the same industry are more expensive than CLDT, based on the Enterprise Value to EBITDA ratio.
CLDT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 9544.11
EV/EBITDA 7.55
CLDT Per share dataCLDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CLDT's earnings are expected to grow with 125.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y125.83%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

CLDT has a Yearly Dividend Yield of 7.96%, which is a nice return.
CLDT's Dividend Yield is a higher than the industry average which is at 6.80.
CLDT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 7.96%

5.2 History

The dividend of CLDT decreases each year by -19.39%.
CLDT has been paying a dividend for at least 10 years, so it has a reliable track record.
CLDT has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-19.39%
Div Incr Years0
Div Non Decr Years2
CLDT Yearly Dividends per shareCLDT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

789.87% of the earnings are spent on dividend by CLDT. This is not a sustainable payout ratio.
DP789.87%
EPS Next 2Y125.83%
EPS Next 3YN/A
CLDT Yearly Income VS Free CF VS DividendCLDT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
CLDT Dividend Payout.CLDT Dividend Payout, showing the Payout Ratio.CLDT Dividend Payout.PayoutRetained Earnings

CHATHAM LODGING TRUST

NYSE:CLDT (8/8/2025, 8:26:21 PM)

After market: 6.82 0 (0%)

6.82

-0.01 (-0.15%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners89.12%
Inst Owner Change0.88%
Ins Owners2.39%
Ins Owner Change0%
Market Cap334.04M
Analysts80
Price Target9.18 (34.6%)
Short Float %1.51%
Short Ratio3.06
Dividend
Industry RankSector Rank
Dividend Yield 7.96%
Yearly Dividend0.46
Dividend Growth(5Y)-19.39%
DP789.87%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-30 2025-06-30 (0.09)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)96.5%
Min EPS beat(2)85.99%
Max EPS beat(2)107%
EPS beat(4)4
Avg EPS beat(4)79.95%
Min EPS beat(4)63.4%
Max EPS beat(4)107%
EPS beat(8)7
Avg EPS beat(8)46.88%
EPS beat(12)11
Avg EPS beat(12)170.64%
EPS beat(16)14
Avg EPS beat(16)132.31%
Revenue beat(2)0
Avg Revenue beat(2)-1.44%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)-1.35%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)-1.11%
Revenue beat(8)1
Avg Revenue beat(8)-1.34%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)8
Avg Revenue beat(16)0.09%
PT rev (1m)0%
PT rev (3m)-8.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-200%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.78%
Valuation
Industry RankSector Rank
PE 16.63
Fwd PE 133.73
P/S 1.05
P/FCF 9544.11
P/OCF 4.7
P/B 0.44
P/tB 0.44
EV/EBITDA 7.55
EPS(TTM)0.41
EY6.01%
EPS(NY)0.05
Fwd EY0.75%
FCF(TTM)0
FCFY0.01%
OCF(TTM)1.45
OCFY21.29%
SpS6.48
BVpS15.41
TBVpS15.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.23%
ROE 0.38%
ROCE 2.74%
ROIC 2.17%
ROICexc 2.2%
ROICexgc 2.2%
OM 10.12%
PM (TTM) 0.89%
GM 75.86%
FCFM 0.01%
ROA(3y)-0.19%
ROA(5y)-1.54%
ROE(3y)-0.33%
ROE(5y)-3%
ROIC(3y)2.14%
ROIC(5y)N/A
ROICexc(3y)2.2%
ROICexc(5y)N/A
ROICexgc(3y)2.2%
ROICexgc(5y)N/A
ROCE(3y)2.7%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-8.5%
ROICexc growth 3YN/A
ROICexc growth 5Y-8.5%
OM growth 3YN/A
OM growth 5Y-10.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.31%
F-Score6
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 10895.6
Debt/EBITDA 4.13
Cap/Depr 117.88%
Cap/Sales 22.4%
Interest Coverage 1.1
Cash Conversion 76.96%
Profit Quality 1.24%
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z 0.4
F-Score6
WACC7.62%
ROIC/WACC0.28
Cap/Depr(3y)85.28%
Cap/Depr(5y)104.02%
Cap/Sales(3y)16.48%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)685.71%
EPS 3YN/A
EPS 5Y-53.5%
EPS Q2Q%260%
EPS Next Y-406%
EPS Next 2Y125.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.96%
Revenue growth 3Y15.86%
Revenue growth 5Y-0.68%
Sales Q2Q%-7.16%
Revenue Next Year-5.98%
Revenue Next 2Y-2.49%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.32%
EBIT growth 3YN/A
EBIT growth 5Y-11.19%
EBIT Next Year189.56%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-99.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.6%
OCF growth 3Y36.89%
OCF growth 5Y-3.06%